Real-world effectiveness and tolerability of highly purified cannabidiol in patients with monogenic developmental and epileptic encephalopathies with highly active epilepsy
Emanuele Cerulli Irelli(Sapienza University of Rome), et al, Francesca Bisulli(Istituto delle Scienze Neurologiche di Bologna), Duccio Maria Cordelli(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Gabriela Reyes Valenzuela(Garrahan Hospital), Ángel Aledo‐Serrano, Jana Domínguez‐Carral(Marqués de Valdecilla University Hospital), Andrea Rüegger(University Children's Hospital Zurich), Lorenza Marini, Georgia Ramantani(University Children's Hospital Zurich), Patrick B. Moloney(Mater Misericordiae University Hospital), Elisabetta Cesaroni, Adolfo Mazzeo(Sapienza University of Rome), Marco Perulli(Community Options (United States)), Laura Licchetta(Istituto delle Scienze Neurologiche di Bologna), Sara Matricardi(Ospedali Riuniti di Ancona), Giancarlo Di Gennaro(Istituto Neurologico Mediterraneo), Susanna Casellato, G Santangelo(Azienda di Rilievo Nazionale ed Alta Specializzazione), Javier Peña-Ceballos, Nicola Simeone, Maria M Mancardi, Valentina De Giorgis, Alia Ramírez-Camacho, Alessandro Ferretti, Francesca F Operto, Roberto H Caraballo, Paolo Bonanni, Tomasz S Mieszczanek, Luca Bergonzini(Istituto delle Scienze Neurologiche di Bologna), Antonella Riva, Giulia Prato(Istituto Giannina Gaslini)
Cited by 0
Related Papers
The Pharmacoresistant Epilepsy: An Overview on Existent and New Emerging Therapies
|Frontiers in Neurology|2021|260
Unstable TTTTA/TTTCA expansions in MARCH6 are associated with Familial Adult Myoclonic Epilepsy type 3
|Nature Communications|2019|170
Molecular characterization of congenital myasthenic syndromes in Spain
|Neuromuscular Disorders|2017|79